Key Pharmacologic Distinction
The American Heart Association clearly distinguishes statins based on their lipophilicity (measured by log P value), where statins with a log P value >0 have greater penetration into fat than water. 1
Hydrophilic (Water-Soluble) Statins:
Lipophilic (Fat-Soluble) Statins:
Clinical Implications of Water Solubility
Hydrophilic statins demonstrate greater hepatoselectivity because they are taken up by active carrier-mediated processes rather than passive diffusion, resulting in reduced potential for uptake by peripheral cells. 3
Metabolism and Drug Interactions:
- Hydrophilic statins (pravastatin and rosuvastatin) are NOT significantly metabolized by cytochrome P450 enzymes, making them less susceptible to drug-drug interactions compared to lipophilic statins. 3
- Pravastatin has minimal protein binding compared to other statins. 1
- Rosuvastatin undergoes minor CYP2C9 metabolism (also CYP2C19), but this is not its primary metabolic pathway. 1
Practical Application in Statin Intolerance:
When evaluating patients for statin-associated side effects, the 2022 ACC Expert Consensus recommends rechallenge with statins metabolized by different pathways and having different lipophilicity/hydrophilicity profiles. 2 The predominantly hydrophilic statins (rosuvastatin and pravastatin) should be tried as alternatives to lipophilic statins when managing statin-associated muscle symptoms. 2
Common Pitfall to Avoid
Do not confuse water solubility with hepatic selectivity or safety profile—while hydrophilic statins show greater hepatoselectivity, this does not automatically translate to superior clinical outcomes or fewer adverse effects in all patient populations. 4 The choice between hydrophilic and lipophilic statins should primarily be guided by drug-drug interaction potential, patient-specific risk factors, and the need for specific LDL-C reduction rather than solubility alone. 1, 2